Company Filing History:
Years Active: 2016
Title: Tamara Danelli: Innovator in Pharmaceutical Chemistry
Introduction
Tamara Danelli is a prominent inventor based in Rodano, Italy. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of crystalline salts for therapeutic applications. Her work is characterized by a focus on innovative solutions that enhance the efficacy of medications.
Latest Patents
Tamara Danelli holds a patent for "Crystalline salts of asenapine." This patent discloses asenapine phosphate of formula (I) and its enantiomer, which can be utilized to prepare asenapine maleate. Additionally, it introduces a monoclinic crystalline form of asenapine maleate, showcasing her expertise in the formulation of pharmaceutical compounds.
Career Highlights
Throughout her career, Tamara has demonstrated a commitment to advancing pharmaceutical science. Her work at Olon S.p.a. has positioned her as a key player in the industry, where she continues to innovate and contribute to the development of new therapeutic agents.
Collaborations
Tamara has collaborated with notable colleagues, including Samuele Frigoli and Davide Longoni. These partnerships have fostered a collaborative environment that enhances research and development efforts within her field.
Conclusion
Tamara Danelli's contributions to pharmaceutical chemistry, particularly through her patent on asenapine salts, highlight her role as an influential inventor. Her work continues to impact the development of effective medications, showcasing the importance of innovation in healthcare.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.